BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zijian Qin, Maolin Wang, Aixia Yan. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM)Bioorganic & Medicinal Chemistry Letters 2017; 27(13): 2931 doi: 10.1016/j.bmcl.2017.05.001
2
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in AmmanBMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
3
Molham Abdulsamad, Ariyo Ihimoyan. Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side EffectCase Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/8627139
4
Angel Hernández-Bartolomé, Rosario López-Rodríguez, María Jesús Borque, Leticia González-Moreno, Yolanda Real-Martínez, Luisa García-Buey, Ricardo Moreno-Otero, Paloma Sanz-Cameno. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis CWorld Journal of Gastroenterology 2016; 22(44): 9744-9751 doi: 10.3748/wjg.v22.i44.9744
5
Amanda Chaney. Cuidar de pacientes con infección crónica por virus de la hepatitis CNursing (Ed. española) 2019; 36(6): 32 doi: 10.1016/j.nursi.2019.11.008
6
Giulia Malaguarnera, Gaetano Bertino, Giuseppe Chisari, Massimo Motta, Michele Vecchio, Marco Vacante, Filippo Caraci, Carmela Greco, Filippo Drago, Giuseppe Nunnari, Michele Malaguarnera. Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work abilityBMC Psychiatry 2016; 16(1) doi: 10.1186/s12888-016-1115-z
7
Giulia Malaguarnera, Gaetano Bertino, Carmela Greco, Caterina Gagliano, Massimo Motta, Giuseppe Chisari, Venerando Rapisarda, Giuseppe Nunnari, Michele Vecchio, Filippo Drago, Michele Malaguarnera. Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational studyTranslational Medicine Communications 2017; 2(1) doi: 10.1186/s41231-016-0010-4
8
S Amele, L Peters, M Sluzhynska, A Yakovlev, A Scherrer, P Domingo, J Gerstoft, JP Viard, M Gisinger, R Flisiak, S Bhaghani, M Ristola, C Leen, E Jablonowska, G Wandeler, H Stellbrink, K Falconer, A D'Arminio Monforte, A Horban, JK Rockstroh, JD Lundgren, A Mocroft. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAHIV Medicine 2019; 20(4): 264 doi: 10.1111/hiv.12711
9
Gaetano Bertino, Giulia Malaguarnera, Evelise Frazzetto, Alice Sciuto, Gaetano Inserra, Guido Nicola Zanghì, Michele Malaguarnera. Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutionsWorld Journal of Hepatology 2018; 10(6): 448-451 doi: 10.4254/wjh.v10.i6.448
10
Ángel Hernández-Bartolomé, Rosario López-Rodríguez, Luisa García-Buey, Samuel Martín-Vílchez, Yolanda Rodríguez-Muñoz, María Jesús Borque, Leticia González-Moreno, Yolanda Real-Martínez, Jorge Mendoza-Ridruejo, Elena Martín-Pérez, Ricardo Moreno-Otero, Paloma Sanz-Cameno. Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systemsLiver International 2017; 37(8): 1148 doi: 10.1111/liv.13352
11
Venerando Rapisarda, Carla Loreto, Michele Malaguarnera, Annalisa Ardiri, Maria Proiti, Giuseppe Rigano, Evelise Frazzetto, Maria Irene Ruggeri, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Vito Emanuele Catania, Isidoro Di Carlo, Adriana Toro, Emanuele Bertino, Dario Mangano, Gaetano Bertino. Hepatocellular carcinoma and the risk of occupational exposureWorld Journal of Hepatology 2016; 8(13): 573-590 doi: 10.4254/wjh.v8.i13.573
12
Almas Shamaila Mohammed, Aniket Balapure, Mahammad Nanne Khaja, Ramakrishnan Ganesan, Jayati Ray Dutta. Naked-eye colorimetric detection of HCV RNA mediated by a 5′ UTR-targeted antisense oligonucleotide and plasmonic gold nanoparticlesThe Analyst 2021; 146(5): 1569 doi: 10.1039/D0AN02481C
13
Serap Beldar, Malathy Sony Subramanian Manimekalai, Nam-Joon Cho, Kwanghee Baek, Gerhard Grüber, Ho Sup Yoon. Self-association and conformational variation of NS5A domain 1 of hepatitis C virus Journal of General Virology 2018; 99(2): 194 doi: 10.1099/jgv.0.001000
14
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospectsEuropean Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
15
Chun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, Hung-Chih Yang, Pei-Jer Chen, Yu-Wen Chen, Jia-Horng Kao, Chun-Jen Liu. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataJournal of Microbiology, Immunology and Infection 2020; 53(4): 569 doi: 10.1016/j.jmii.2018.09.005
16
Helena H.L. Borba, Ursula Rochau, Astrid Wiens, Gaby Sroczynski, Uwe Siebert, Vinicius L. Ferreira, Eimy Minowa, Roberto Pontarolo. Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System PerspectiveValue in Health Regional Issues 2019; 20: 95 doi: 10.1016/j.vhri.2019.02.005
17
Sern Wei Yeoh, Alex C. N. Holmes, Michael M. Saling, Ian P. Everall, Amanda J. Nicoll. Depression, fatigue and neurocognitive deficits in chronic hepatitis CHepatology International 2018; 12(4): 294 doi: 10.1007/s12072-018-9879-5
18
Waleed A. Ismail, Ayman E. Yousef. Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasisEuropean Journal of Gastroenterology & Hepatology 2019; 31(8): 1025 doi: 10.1097/MEG.0000000000001370
19
D. E. Valutite, A. V. Semenov, Yu. V. Ostankova, K. V. Kozlov, A. G. Borisov, V. D. Nazarov, A. A. Totolian. Detection of drug resistance mutations of hepatitis C virus in patients with failure of the treatment with direct acting antiviralsJournal of microbiology, epidemiology and immunobiology 2021; 98(1): 18 doi: 10.36233/0372-9311-47
20
Jeffrey L. Roberson, Virginia L. Kan. Hepatitis C Virus Continuum of Care in the Interferon and Direct-Acting Agent Eras Among HIV-Coinfected PatientsAIDS Research and Human Retroviruses 2017; 33(5): 405 doi: 10.1089/aid.2016.0170
21
J. Bagg, K. Roy, L. Hopps, I. Black, D. Croser, C. O'Halloran, F. Ncube. No longer 'written off' – times have changed for the BBV-infected dental professionalBritish Dental Journal 2017; 222(1): 47 doi: 10.1038/sj.bdj.2017.36
22
Florian Bayer, Benoît Audry, Corinne Antoine, Carine Jasseron, Camille Legeai, Olivier Bastien, Christian Jacquelinet. Removing administrative boundaries using a gravity model for a national liver allocation systemAmerican Journal of Transplantation 2021; 21(3): 1080 doi: 10.1111/ajt.16214
23
R. Ragusa, G. Bertino, A. Bruno, E. Frazzetto, F. Cicciu, G. Giorgianni, L. Lupo. Evaluation of health status in patients with hepatitis c treated with and without interferonHealth and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0842-x
24
Chun-Ming Hong, Chun-Jen Liu, Shiou-Hwei Yeh, Pei-Jer Chen. Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved responseJournal of the Formosan Medical Association 2017; 116(4): 295 doi: 10.1016/j.jfma.2016.11.014
25
Tessa M Nápoles, Abigail W Batchelder, Ada Lin, Lissa Moran, Mallory O Johnson, Martha Shumway, Anne F Luetkemeyer, Marion G Peters, Kellene V Eagen, Elise D Riley. HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA eraJournal of Public Health 2019; 41(4): e283 doi: 10.1093/pubmed/fdz045
26
Stefania Notari, Massimo Tempestilli, Gabriele Fabbri, Raffaella Libertone, Andrea Antinori, Adriana Ammassari, Chiara Agrati. UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patientsJournal of Chromatography B 2018; 1073: 183 doi: 10.1016/j.jchromb.2017.12.018
27
Naser F. Al-Tannak, Ahmed Hemdan, Maya S. Eissa. Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug MonitoringInternational Journal of Analytical Chemistry 2018; 2018: 1 doi: 10.1155/2018/6535816
28
Jonathan Schmelzer, Ellen Dugan, Sarah Blach, Samantha Coleman, Zongzhen Cai, Mindi DePaola, Chris Estes, Ivane Gamkrelidze, Kathryn Jerabek, Siyi Ma, Shauna Montoya, Devin Razavi-Shearer, Kathryn Razavi-Shearer, Sarah Robbins-Scott, Homie Razavi, Manal Hamdy El Sayed. Global prevalence of hepatitis C virus in children in 2018: a modelling studyThe Lancet Gastroenterology & Hepatology 2020; 5(4): 374 doi: 10.1016/S2468-1253(19)30385-1
29
Amanda Chaney. Caring for patients with chronic hepatitis C infectionNursing 2019; 49(3): 36 doi: 10.1097/01.NURSE.0000553271.39804.a4
30
Jeffrey L. Roberson, Alicia M. Lagasca, Virginia L. Kan. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008–2015AIDS Research and Human Retroviruses 2018; 34(2): 148 doi: 10.1089/aid.2017.0092
31
Marleen H. M. Hessel, Adam F. Cohen, Robert Rissmann. Sofosbuvir and daclatasvirBritish Journal of Clinical Pharmacology 2016; 82(3): 878 doi: 10.1111/bcp.13011
32
Rosario López-Rodríguez, Ángel Hernández-Bartolomé, María Jesús Borque, Yolanda Rodríguez-Muñoz, Samuel Martín-Vílchez, Luisa García-Buey, Leticia González-Moreno, Yolanda Real-Martínez, Paloma Muñoz de Rueda, Javier Salmerón, José Ramón Vidal-Castiñeira, Carlos López-Larrea, Luis Rodrigo, Ricardo Moreno-Otero, Paloma Sanz-Cameno, Matias A. Avila. Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis CPLOS ONE 2017; 12(7): e0180927 doi: 10.1371/journal.pone.0180927
33
V A Malov, E A Ubeeva, I P Ubeeva, S M Nikolaev, K T Umbetova. Treatment of chronic viral hepatitis C with direct acting antiviral agent: reviewTerapevticheskii arkhiv 2019; 91(11): 86 doi: 10.26442/00403660.2019.11.000307
34
Ricard Masia, Joseph Misdraji. Diagnostic Pathology of Infectious Disease2018; : 272 doi: 10.1016/B978-0-323-44585-6.00011-4
35
Rosario Gravier-Hernández, Lizette Gil-del Valle, Lindunka Valdes-Alonso, Nadiecha Hernández-Ayala, Yusimit Bermúdez-Alfonso, Daymé Hernández-Requejo, Teresa Rosell-Guerra, Maria C. Hernández-González-Abreu. Oxidative stress in hepatitis C virus–human immunodeficiency virus co-infected patientsAnnals of Hepatology 2020; 19(1): 92 doi: 10.1016/j.aohep.2019.05.009
36
Manal El‐Hamamsy, Iman Fawzy Montasser, Azza El‐Sayed Mansy, Dina Ezzeldin Nabet, Mahmoud El‐Meteini. Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype‐4 recurrence post–liver transplantation: A prospective cohort trialJournal of Clinical Pharmacy and Therapeutics 2019; 44(3): 447 doi: 10.1111/jcpt.12807
37
Juliana Cristina Santiago Bastos, Marina Aiello Padilla, Leonardo Cardia Caserta, Noelle Miotto, Aline Gonzalez Vigani, Clarice Weis Arns. Hepatitis C virus: Promising discoveries and new treatmentsWorld Journal of Gastroenterology 2016; 22(28): 6393-6401 doi: 10.3748/wjg.v22.i28.6393
38
Stefania Bartoloni, Stefano Leone, Filippo Acconcia. Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast CancerInternational Journal of Molecular Sciences 2020; 21(10): 3418 doi: 10.3390/ijms21103418
39
Manuela Pennisi, Gaetano Bertino, Caterina Gagliano, Michele Malaguarnera, Rita Bella, Antonio Borzì, Roberto Madeddu, Filippo Drago, Giulia Malaguarnera. Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep DisturbanceNutrients 2017; 9(8): 897 doi: 10.3390/nu9080897
40
Ossama Ashraf Ahmed, Eslam Safwat, Mohamed Omar Khalifa, Ahmed I. Elshafie, Mohamed Hassan Ahmed Fouad, Mohamed Magdy Salama, Gina Gamal Naguib, Mohamed Mahmoud Eltabbakh, Ahmed Fouad Sherief, Sherief Abd-Elsalam. Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian VillageInternational Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9616234
41
Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) PolymeraseViruses 2017; 9(6): 151 doi: 10.3390/v9060151
42
Amanda Mocroft, Jens D Lundgren, Juergen K Rockstroh, Inka Aho, Gilles Wandeler, Lars Nielsen, Simon Edwards, Jean-Paul Viard, Karine Lacombe, Gerd Fätkenheuer, Giovanni Guaraldi, Montserrat Laguno, Josep Llibre, Hila Elinav, Leo Flamholc, Martin Gisinger, Dzmitry Paduta, Irina Khromova, David Jilich, Blazej Rozplochowski, Cristiana Oprea, Lars Peters, A Harxhi, M Losso, M Kundro, B Schmied, R Zangerle, I Karpov, A Vassilenko, D Paduto, N Clumeck, S De Wit, M Delforge, E Florence, L Vandekerckhove, V Hadziosmanovic, J Begovac, L Machala, D Jilich, D Sedlacek, G Kronborg, T Benfield, J Gerstoft, T Katzenstein, C Pedersen, I S Johansen, L Ostergaard, L Wiese, N F Moller, K Zilmer, I Aho, J-P Viard, P-M Girard, C Pradier, E Fontas, C Duvivier, J Rockstroh, G Behrens, O Degen, H J Stellbrink, J Bogner, G Fätkenheuer, N Chkhartishvili, H Sambatakou, G Adamis, N Paissios, J Szlávik, M Gottfredsson, C Kelly, L Tau, D Turner, M Burke, E Shahar, G Hassoun, H Elinav, M Haouzi, D Elbirt, A D’arminio Monforte, R Esposito, I Mazeu, C Mussini, F Mazzotta, A Gabbuti, A Lazzarin, A Castagna, N Gianotti, M Galli, A Ridolfo, V Uzdaviniene, R Matulionyte, T Staub, R Hemmer, S Dragas, M Stevanovic, P Reiss, J Trajanovska, D H Reikvam, A Maeland, J Bruun, B Knysz, J Gasiorowski, M Inglot, E Bakowska, R Flisiak, A Grzeszczuk, M Parczewski, K Maciejewska, B Aksak-Was, M Beniowski, E Mularska, E Jablonowska, J Kamerys, K Wojcik, I Mozer-Lisewska, B Rozplochowski, A Zagalo, K Mansinho, F Maltez, C Oprea, A Yakovlev, I Khromova, E Kuzovatova, E Borodulina, E Vdoushkina, J Ranin, J Tomazic, J M Miro, M Laguno, E Martinez, F Garcia, J L Blanco, M Martinez-Rebollar, J Mallolas, P Callau, J Rojas, A Inciarta, S Moreno, B Clotet, A Jou, R Paredes, J Puig, J M Llibre, J R Santos, P Domingo, M Gutierrez, G Mateo, M A Sambeat, J M Laporte, K Falconer, A Thalme, A Sonnerborg, C J Treutiger, L Flamholc, A Scherrer, R Weber, M Cavassini, A Calmy, H Furrer, M Battegay, P Schmid, A Kuznetsova, J Mikhalik, M Sluzhynska, A Milinkovic, A M Johnson, E Simons, S Edwards, A Phillips, M A Johnson, A Mocroft, A Winston, A Clarke, C Leen, I Karpov, M Losso, J Lundgren, J Rockstroh, I Aho, L D Rasmussen, V Svedhem, G Wandeler, C Pradier, N Chkhartishvili, R Matulionyte, C Oprea, J D Kowalska, J Begovac, J M Miró, G Guaraldi, R Paredes, G Wandeler, R Paredes, O Kirk, L Peters, A Bojesen, D Raben, E V Hansen, D Kristensen, J F Larsen, A H Fischer, A Mocroft, A Phillips, A Cozzi-Lepri, S Amele, A Pelchen-Matthews, A Roen. Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive PersonsOpen Forum Infectious Diseases 2020; 7(12) doi: 10.1093/ofid/ofaa470
43
Meryl Waldman, Howard A. Austin, James E. Balow. Clinical Immunology2019; : 917 doi: 10.1016/B978-0-7020-6896-6.00068-5
44
Dana Busschots, Cécile Kremer, Özgür M. Koc, Leen Heyens, Rob Bielen, Ludwig Apers, Eric Florence, Peter Messiaen, Kristel Van Laethem, Eric Van Wijngaerden, Frederik Nevens, Niel Hens, Geert Robaeys. The hepatitis C cascade of care in the Belgian HIV population: One step closer to eliminationInternational Journal of Infectious Diseases 2021; 105: 217 doi: 10.1016/j.ijid.2021.02.068
45
Sebastián Marciano, Leila Haddad, Fernando Plazzotta, Ezequiel Mauro, Sergio Terraza, Sanjeev Arora, Karla Thornton, Beatriz Ríos, Carlos García Dans, Natalia Ratusnu, Liliana Calanni, José Allevato, María Ester Sirotinsky, Marcos Pedrosa, Adrián Gadano. Implementation of the ECHO ® telementoring model for the treatment of patients with hepatitis C Journal of Medical Virology 2017; 89(4): 660 doi: 10.1002/jmv.24668
46
Federico Salomone, Maurizio Catania, Arturo Montineri, Gaetano Bertino, Justyna Godos, Leonardo Rizzo, Giovanni Magrì, Giovanni Li Volti. Hepatitis C virus eradication by direct antiviral agents improves glucose tolerance and reduces post-load insulin resistance in nondiabetic patients with genotype 1Liver International 2018; 38(7): 1206 doi: 10.1111/liv.13669
47
Vito Emanuele Catania, Giulia Malaguarnera, Giorgia Fiorenza, Eleonora Margherita Chisari, Anna Rita Lipari, Valentino Gallina, Manuela Pennisi, Giuseppe Lanza, Michele Malaguarnera. Hepatitis C Virus Infection Increases Fatigue in Health Care WorkersDiseases 2020; 8(4): 37 doi: 10.3390/diseases8040037
48
Yuqian Yan, Ning Liang, Shibing Liang, Yuxin Sun, Nicola Robinson, Jianping Liu. Evaluation of outcomes reported in randomized controlled trials for herbal remedies for adults with chronic hepatitis CJournal of Traditional Chinese Medical Sciences 2019; 6(2): 115 doi: 10.1016/j.jtcms.2019.03.002
49
Amanda Mocroft, Lene Ryom, Cristiana Oprea, Qiuju Li, Andri Rauch, Christoph Boesecke, Vilma Uzdaviniene, Dalibor Sedlacek, Josep M. Llibre, Karine Lacombe, Lars N. Nielsen, Eric Florence, Inka Aho, Nikoloz Chkhartishvili, János Szlavik, Gordana Dragovic, Clifford Leen, Helen Sambatakou, Therese Staub, Montse Laguno, Hila Elinav, Janez Tomažič, Lars Peters. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive personsAIDS 2020; 34(10): 1485 doi: 10.1097/QAD.0000000000002570